The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 185 articles
Double chimney stenting without contrast during transcatheter aortic valve-in-valve implantation
January 23, 2023 | 10.4244/EIJ-D-22-00385
Pre-procedural planning of coronary revascularization by cardiac computed tomography: An expert consensus document of the Society of Cardiovascular Computed Tomography
Andreini D,
Collet C,
Leipsic J,
Nieman K,
Bittencurt M,
De Mey J,
Buls N,
Onuma Y,
Mushtaq S,
Conte E,
Bartorelli AL,
Stefanini G,
Sonck J,
Knaapen P,
Ghoshhajra B,
Serruys P
December 2, 2022 | 10.4244/EIJ-E-22-00036
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter RJ,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg PG,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson T,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial
van Geuns R,
Chun-Chin C,
McEntegart M,
Merkulov E,
Kretov E,
Lesiak M,
O’Kane P,
Hanratty C,
Bressollette E,
Silvestri M,
Wlodarczak A,
Barragan P,
Anderson R,
Protopopov A,
Peace A,
Menown I,
Rocchiccioli P,
Onuma Y,
Oldroyd K
April 22, 2022 | 10.4244/EIJ-D-21-00514
A comparison of risk prediction models for patients with acute coronary syndromes
March 18, 2022 | 10.4244/EIJ-D-21-00536
Reply: Composite endpoints in clinical trials - simplicity or perfection?
January 28, 2022 | 10.4244/EIJ-D-21-00440R
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials
Azzalini L,
Ellis S,
Kereiakes D,
Kimura T,
Gao R,
Onuma Y,
Chevalier B,
Dressler O,
Crowley A,
Zhou Z,
Redfors B,
Serruys P,
Stone G
December 17, 2021 | 10.4244/EIJ-D-21-00263
Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial
Faria D,
Lee JM,
van de Hoef TP,
Mejía-Rentería H,
Echavarria-Pinto M,
Baptista S,
Cerrato E,
Garcia-Garcia H,
Davies J,
Onuma Y,
Samady H,
Piek J,
Serruys P,
Lerman A,
Escaned J
October 20, 2021 | 10.4244/EIJ-D-20-01163
Statistical methods for composite endpoints
Hara H,
van Klaveren D,
Kogame N,
Chichareon P,
Modolo R,
Tomaniak M,
Ono M,
Kawashima H,
Takahashi K,
Capodanno D,
Onuma Y,
Serruys P
April 2, 2021 | 10.4244/EIJ-D-19-00953
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y,
Muramatsu T,
Asano T,
Katagiri Y,
Sotomi Y,
Nakatani S,
Takahashi K,
Kogame N,
Higuchi Y,
Ishikawa M,
Kyono H,
Yano M,
Ozaki Y,
Serruys P,
Okamura T,
Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter RJ,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Coronary interventions in 2020: the year in review
February 5, 2021 | 10.4244/EIJ-D-20-01343
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys P
December 18, 2020 | 10.4244/EIJ-D-20-00772
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023